dce-mri abstract.pdf (11.99 kB)
Download file

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC).

Download (11.99 kB)
conference contribution
posted on 11.10.2007, 17:12 by Mark A. Horsfield, Bruno Morgan, H. Krissel, Dirk Laurent
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC).

History

Citation

Annals of Oncology, 2006, 17(Supplement 9), p.ix219

Published in

Annals of Oncology

Publisher

Oxford University Press

Available date

11/10/2007

Notes

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Annals of Oncology following peer review. The definitive publisher-authenticated version [Annals of Oncology, 2006, 17(Supplement 9), abstract PD732] is available online at: http://annonc.oxfordjournals.org/. This is an abstract of a paper presented at the 31st ESMO Congress 29 September - 3 October, 2006: Istanbul, Turkey. The published versions lists additional authors.

Language

en

Usage metrics

Categories

Keywords

Exports